Venous Thromboembolism

• CLINICAL_TRIALS trial_result · 2008-05-16
  Clinical Trial Update: Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers [Phase 2]

  Phase 2 clinical trial completed evaluating the therapeutic dosage of fondaparinux sodium to prevent blood clots in morbidly obese volunteer…

• CLINICAL_TRIALS trial_result · 2008-03-31
  Clinical Trial Update: New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery [Phase 2]

  Phase 2 trial evaluating a new oral anticoagulant to prevent venous thromboembolism after total hip or total knee replacement has completed.

• FDA approval · 2008-03-28
  FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)

  The FDA approved a supplemental application for Jantoven (warfarin sodium) filed by Upsher-Smith Laboratories, LLC.

• CLINICAL_TRIALS research · 2008-02-01
  Clinical Trial Update: Venous Thrombosis in Turner Syndrome

  An update on a clinical trial examining venous thrombosis risk in Turner syndrome. The trial status is unknown.

• FDA approval · 2007-12-14
  FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)

  FDA approved Civica, Inc.'s supplemental application for HEPARIN SODIUM. This action approves a supplemental NDA related to the product (NDA…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2007-12-11
  Clinical Trial Update: Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter [Phase 4]

  A completed Phase 4 clinical study evaluating retrieval of the Günther Tulip vena cava filter, conducted in patients with pulmonary embolism…

• CLINICAL_TRIALS trial_result · 2007-10-10
  Clinical Trial Update: Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery [Phase 2]

  Pfizer completed a Phase 2 trial evaluating PD 0348292 for preventing venous thromboembolism (deep vein thrombosis and pulmonary embolism) a…

• CLINICAL_TRIALS other · 2007-07-16
  Clinical Trial Update: Sleep Apnea and Tromboembolic Disease

  Clinical trial update involving sleep apnea and venous thromboembolism; current status is unknown.

• FDA approval · 2007-07-11
  FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Warfarin Sodium from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA.

• CLINICAL_TRIALS trial_result · 2007-04-27
  Clinical Trial Update: Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients [Phase 3]

  Phase 3 trial evaluating dalteparin for primary prophylaxis of venous thromboembolism in brain tumor patients has completed; no results are …

• CLINICAL_TRIALS research · 2007-04-11
  Clinical Trial Update: Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

  A clinical trial update examining whether hypercoagulable parameters can predict thrombotic events and prognosis in patients with advanced n…

• CLINICAL_TRIALS trial_result · 2007-02-21
  Clinical Trial Update: Thromboprophylaxis in Critically Ill Patients [Phase 4]

  A Phase 4 clinical trial evaluating thromboprophylaxis in critically ill patients for venous thromboembolism was terminated.

• CLINICAL_TRIALS trial_result · 2007-02-09
  Clinical Trial Update: Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [Phase 4]

  The Main LITE study comparing low-molecular-weight heparin to warfarin for long-term treatment of proximal deep vein thrombosis has complete…

• CLINICAL_TRIALS trial_result · 2007-02-09
  Clinical Trial Update: Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin [Phase 4]

  A Phase 4 trial comparing long-term out-of-hospital treatment of proximal deep vein thrombosis with low-molecular-weight heparin alone versu…

• CLINICAL_TRIALS trial_result · 2006-11-17
  Clinical Trial Update: PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) [Phase 3]

  Phase 3 PROTECT Pilot trial update on prophylaxis for thromboembolism in critically ill patients; the trial status is completed.

• FDA approval · 2006-07-05
  FDA Approved: WARFARIN SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approves Teva's Warfarin Sodium generic under an Original Application (ANDA) for this oral anticoagulant.

• FDA approval · 2006-05-05
  FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)

  FDA approved a supplemental application for JANTOVEN (warfarin sodium) from Upsher-Smith Laboratories, LLC.